to Banking & Insurance (H)
Summary
The bill forces all health benefit plans in Kentucky to provide at least two medically necessary epinephrine devices to each enrollee annually and caps any cost‑sharing for those devices at $100 per year. It also adds reporting and cost‑sharing rules for qualified health plans, and ties the new requirement to Medicaid managed‑care plans. The goal is to make life‑saving allergy treatment more affordable and accessible.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 32 changes status, plus AI-powered summaries and stage predictions.
Sign up free